WhatsApp Us
+91 886 141 4344
Chat with Us
hospital_bg
Pharma & Biotech

Genomic Intelligence for Translational Research, Biomarkers, and Drug Development

Genix.ai supports pharma and biotech teams with AI-assisted genomic intelligence to accelerate biomarker discovery, improve cohort stratification, and enable data-driven decisions across the drug development lifecycle.

Clinical genomics platform visualization

The Challenge in Pharma & Biotech Genomics

Pharma and biotech organizations generate vast amounts of genomic and clinical data—but extracting value remains difficult

Genomics workflows
Bioinformatics expertise
Interpretation times
Genomics workflows
Bioinformatics expertise
Scalability

Disconnected genomics, clinical, and omics datasets

Limited ability to stratify patients accurately

Manual, non-reproducible biomarker workflows

AI models that lack explainability or auditability

Difficulty translating research insights into clinical development

How Genix.ai Supports Pharma & Biotech Teams

Genix.ai provides a research- and development-ready genomics intelligence platform that bridges discovery, translation, and clinical application.

Analyze genomic data with clinical

population context

Identify and validate biomarkers

Build reproducible, explainable

Support decision-making across R&D Clinic

key hospital use cases

Biomarker Discovery & Validation

Patient & Cohort Stratification

Translational Research

Clinical Development Support

use_cases1
use_cases2
use_cases3
use_cases4

How the Platform Fits into R&D Workflows

01

Data Integration

aaa1
02

Analytical Processing

aaa2
03

Interpretation & Review

aaa3
04

Insight Delivery

aaa4
Genix.ai’s Philosophy

BUILT FOR SCIENTIFIC RIGOR AND REPRODUCIBILITY

Genix.ai is built with hospital realities in mind

Capa_1

Transparent AI-assisted suggestions

Capa_1

Versioned workflows and annotations

Capa_1

Clear separation of AI suggestions and expert conclusions

Capa_1

Reproducible pipelines

Security, Privacy & Collaboration Readiness

Pharma and biotech organizations trust Genix.ai because the platform supports

hospital health

Secure collaboration across internal and external teams

diagon lab

Controlled access to sensitive datasets

Pharma

Deployment flexibility (Private VPC and On-Premise preferred)

Research

Alignment with data governance

Safe and Secure
Public Health

compliance requirements

Deployment options for hospitals

Hospitals can choose the model that best fits their policy and risk posture

SaaS

SaaS

For early-stage exploration and pilots

On-Premise

On-Premise

For sensitive or regulated datasets

Private VPC

Private VPC

Preferred for R&D and clinical programs

Why Pharma & Biotech Teams Choose Genix.ai

whylogopharma

Accelerated biomarker discovery

whylogopharma

Improved patient stratification

whylogopharma

Explainable, audit-ready AI

whylogopharma

Scalable from research to clinical programs

whylogopharma

Designed for long-term R&D partnerships

Why hospitals choose genix.ai

Who Uses Genix.ai in Pharma & Biotech

whylogopharma

Translational medicine teams

whylogopharma

Biomarker and genomics scientists

whylogopharma

Clinical development leaders

whylogopharma

Data science and informatics teams

whylogopharma

External research collaborators

Why hospitals choose genix.ai

Start a Conversation

Share a few details and our team will connect with you

User icon
Email icon
Organization icon
Organization type icon
Role icon
Service icon

Frequently Ask Questions

1. How does Genix.ai accelerate the biomarker discovery and validation process?
Genix.ai provides an integrated environment for multi-omic data analysis. By combining genomics with phenotypic and clinical metadata, our AI-assisted prioritization layers identify high-confidence biomarker candidates. The platform automates evidence aggregation from global databases (ClinVar, COSMIC, gnomAD), allowing R&D teams to move from raw data to validated targets in a fraction of the traditional time.
2. Can the platform support patient stratification for clinical trials?
Yes. Our "Population-Aware Intelligence" allows researchers to stratify cohorts based on complex genotype-phenotype relationships. This helps in identifying responders vs. non-responders early in the development cycle, improving trial efficiency, reducing safety risks, and increasing the overall success rate of late-stage trials.
3. How do you ensure the reproducibility of R&D pipelines?
Scientific rigor is our priority. Every analytical workflow in Genix.ai is versioned and auditable. We follow "FAIR" (Findable, Accessible, Interoperable, Reusable) data principles, ensuring that any insight generated can be traced back to its raw data source and specific software version, meeting the requirements for regulatory submissions.
4.Does the platform integrate with existing bioinformatics tools and pipelines?
Absolutely. We provide a Developer-Friendly API and support for standard formats (VCF, FASTQ, BAM). Whether you want to use Genix.ai as a standalone SaaS or integrate our AI annotation layers into your existing Python/R-based pipelines (e.g., Nextflow or Snakemake), our infrastructure is built to be modular and interoperable.
5. What deployment models are available for sensitive IP and clinical data?
Recognizing the value of your intellectual property, we offer:
  • Private VPC: A dedicated, isolated cloud environment.
  • On-Premise: For highly regulated data where sovereignty is mandatory.
  • SaaS: For early-stage exploration and pilot programs.
6. How do you handle "Black Box" concerns in AI modeling?
We avoid non-traceable predictions. Every AI suggestion is "Explainable by Design," providing researchers with the underlying clinical evidence, statistical confidence scores, and literature references used to generate the insight. This transparency is critical for internal peer review and regulatory transparency.
7. Can Genix.ai handle multi-omic datasets beyond genomics?
Our platform architecture is built for multi-modal data. While genomics is our core, we support the integration of transcriptomics, proteomics, and clinical EHR data to provide a holistic biological view of disease progression and treatment response.
8. Is the platform ready for regulatory audits and GxP compliance?
Yes. Genix.ai features robust role-based access controls (RBAC), end-to-end data encryption, and comprehensive audit logs. Our security architecture is aligned with HIPAA, GDPR, and DPDP standards, ensuring readiness for clinical development and regulatory scrutiny.

Bring Clinical Genomics into Routine Hospital Care

If your hospital or health system is evaluating how to operationalize genomics responsibly and at scale, Genix.ai can support your journey.

Genix.ai - Genomic Precision Wellness
Genix.ai Logo

Genix.ai is an AI-powered clinical platform using NGS and imaging to detect biomarkers early, enabling clinicians to deliver cost-effective, personalized treatments for rare pediatric conditions, cancer care, and infectious diseases.

©2026 Radiome Health Private Limited.

Developed in Association with Chadura.